undamentalytics Newsletter
Sign in

Opko Health, Inc. income statement

In fiscal 2025, Opko Health, Inc. reported revenue of $607m, down 14.9% on the year before, operating income of −$117m (a -19.3% margin) and net income of −$226m, or −$0.30 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue428284797914921,1179669909021,4351,7751,004863713607588
Cost of revenue3131728109193564—————716545495401348
Gross profit21511198682298553—————288318219206240
Research and development116112054849911412612611875777490105124125
Selling, general and administrative101819285558197407415358343356469373301304223206
Operating income−22−11−23−37−80−146−98−97−276−171−2745819−226−157−152−117−48
Interest expense211—————————191214470−63
Income before tax−24−12−24−37−104−171−138−97−272−177−30549−14−392−184−10−241−80
Income tax−0−0−19−1020−114−5619−3971815−63443−16−7
Net income−30−19−1−29−114−172−30−48−305−153−31531−30−328−189−53−226−73
Diluted EPS—−$0.08−$0.01−$0.11−$0.32−$0.41−$0.06−$0.10−$0.55−$0.27−$0.53$0.05−$0.05−$0.46−$0.25−$0.08−$0.30−$0.10
Diluted shares (average)233m255m281m296m355m422m488m556m559m563m595m641m648m719m752m694m751m765m
EBITDA−22−9−19−27−64−131−560−174−74−18014397−118−52−54−2641

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ALVO vs OPKEBS vs OPKOPK vs TVTX

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Opko Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Opko Health, Inc.